Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Nuvo Pharmaceuticals Inc NRIFF


Primary Symbol: MRVFF

Nuvo Pharmaceuticals Inc is a Canadian focused healthcare company doing business as Miravo Healthcare with global reach and a diversified portfolio of commercial products. Its product targets several therapeutic areas, including pain, allergy, and dermatology. The company's strategy is to in-license and acquire growth-oriented, complementary products for Canadian and international markets.


OTCQX:MRVFF - Post by User

Bullboard Posts
Comment by HippygirL74on Dec 04, 2009 3:16pm
504 Views
Post# 16555592

RE: RE: RE: The Lights are on - but the store is e

RE: RE: RE: The Lights are on - but the store is eOn the short term:  imo, it might be good to buy about now and sell as the shorts cover before Dec 14.  The shorters are disciplined on the short term so a 10% return in two weeks is excellent.  They have tax-loss selling on their side helping to keep the price down.  But when they cover before Dec. 14, the price will most likely go up.  Let's see what happens by Dec. 14.  Generally, December is the best time to buy stocks.

On the medium term: Since the last news, they said the launch would be in the first half of 2010, so the schedule has been moved up from the original "second" half of 2010.  We may see some good numbers by Q3- 2010, but the market should move ahead of this, so i would expect the sp to move higher early in the new year. 

On the longer term:  If the competition can sell so many Millions, then i am confident that Covidien and Nuvo will get a nice share of the market too.  imo, if the Canadian market is $10MM and Greece is $10MM, surely, the USA will be at least $100 MM early on.  And add to that the cash position of about
.11 per share, and i'd say that we are undervalued by Mr. Market for sure. 

Once Pennsaid gets some traction, Pennsaid Plus should fit right in as the brand name becomes more familiar.
Bullboard Posts

USER FEEDBACK SURVEY ×

Be the voice that helps shape the content on site!

At Stockhouse, we’re committed to delivering content that matters to you. Your insights are key in shaping our strategy. Take a few minutes to share your feedback and help influence what you see on our site!

The Market Online in partnership with Stockhouse